The Unique Role of Fluorodeoxyglucose-PET in Radioembolization

Remco Bastiaannet; Martin A. Lodge; Hugo W.A.M. de Jong; Marnix G.E.H. Lam

doi:10.1016/j.cpet.2019.06.002

The Unique Role of Fluorodeoxyglucose-PET in Radioembolization

Remco Bastiaannet, Martin A. Lodge, Hugo W.A.M. de Jong, Marnix G.E.H. Lam

School of Medicine

Research output: Contribution to journal › Review article › peer-review

Abstract

Recent research into the efficacy of radioembolization has brought this field to an interesting position, in which fluorodeoxyglucose (FDG)-PET/CT is being used extensively for prognosis and response assessment, as well as a tool to define viable tumor volumes for the use in dosimetry. As such, there is an overlap with existing techniques used in radiotherapy; however, many are very specific to the radioembolization paradigm. This article describes the current state-of-the-art of the use of FDG-PET/CT for patient selection, prognosis, treatment evaluation, and as a research tool into absorbed dose-response relationships in radioembolization.

Original language	English (US)
Pages (from-to)	447-457
Number of pages	11
Journal	PET Clinics
Volume	14
Issue number	4
DOIs	https://doi.org/10.1016/j.cpet.2019.06.002
State	Published - Oct 2019

Keywords

Dose–response
FDG-PET
Metabolic response assessment
Radioembolization

ASJC Scopus subject areas

Radiation
Radiology Nuclear Medicine and imaging

Access to Document

10.1016/j.cpet.2019.06.002

Fingerprint Dive into the research topics of 'The Unique Role of Fluorodeoxyglucose-PET in Radioembolization'. Together they form a unique fingerprint.

Cite this

@article{706d70504e0543e6ab2531c6300e7491,

title = "The Unique Role of Fluorodeoxyglucose-PET in Radioembolization",

abstract = "Recent research into the efficacy of radioembolization has brought this field to an interesting position, in which fluorodeoxyglucose (FDG)-PET/CT is being used extensively for prognosis and response assessment, as well as a tool to define viable tumor volumes for the use in dosimetry. As such, there is an overlap with existing techniques used in radiotherapy; however, many are very specific to the radioembolization paradigm. This article describes the current state-of-the-art of the use of FDG-PET/CT for patient selection, prognosis, treatment evaluation, and as a research tool into absorbed dose-response relationships in radioembolization.",

keywords = "Dose–response, FDG-PET, Metabolic response assessment, Radioembolization",

author = "Remco Bastiaannet and Lodge, {Martin A.} and {de Jong}, {Hugo W.A.M.} and Lam, {Marnix G.E.H.}",

year = "2019",

month = oct,

doi = "10.1016/j.cpet.2019.06.002",

language = "English (US)",

volume = "14",

pages = "447--457",

journal = "PET Clinics",

issn = "1556-8598",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - The Unique Role of Fluorodeoxyglucose-PET in Radioembolization

AU - Bastiaannet, Remco

AU - Lodge, Martin A.

AU - de Jong, Hugo W.A.M.

AU - Lam, Marnix G.E.H.

PY - 2019/10

Y1 - 2019/10

N2 - Recent research into the efficacy of radioembolization has brought this field to an interesting position, in which fluorodeoxyglucose (FDG)-PET/CT is being used extensively for prognosis and response assessment, as well as a tool to define viable tumor volumes for the use in dosimetry. As such, there is an overlap with existing techniques used in radiotherapy; however, many are very specific to the radioembolization paradigm. This article describes the current state-of-the-art of the use of FDG-PET/CT for patient selection, prognosis, treatment evaluation, and as a research tool into absorbed dose-response relationships in radioembolization.

AB - Recent research into the efficacy of radioembolization has brought this field to an interesting position, in which fluorodeoxyglucose (FDG)-PET/CT is being used extensively for prognosis and response assessment, as well as a tool to define viable tumor volumes for the use in dosimetry. As such, there is an overlap with existing techniques used in radiotherapy; however, many are very specific to the radioembolization paradigm. This article describes the current state-of-the-art of the use of FDG-PET/CT for patient selection, prognosis, treatment evaluation, and as a research tool into absorbed dose-response relationships in radioembolization.

KW - Dose–response

KW - FDG-PET

KW - Metabolic response assessment

KW - Radioembolization

UR - http://www.scopus.com/inward/record.url?scp=85069930531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069930531&partnerID=8YFLogxK

U2 - 10.1016/j.cpet.2019.06.002

DO - 10.1016/j.cpet.2019.06.002

M3 - Review article

C2 - 31472742

AN - SCOPUS:85069930531

VL - 14

SP - 447

EP - 457

JO - PET Clinics

JF - PET Clinics

SN - 1556-8598

IS - 4

ER -